Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Artigo em Inglês | IMSEAR | ID: sea-156366

RESUMO

Background. Disseminated histoplasmosis is a chronic granulomatous disease caused by the dimorphic fungus, Histoplasma capsulatum. Clinical presentation can vary from the acute pulmonary to the chronic disseminated form. In India, disseminated histoplasmosis often presents with pyrexia of unknown origin with a presentation similar to ‘disseminated tuberculosis’ involving the adrenal glands and bone marrow. Due to rarity of the disease, data are lacking regarding its clinical presentation and outcome among immunocompromised and immunocompetent patients. Methods. During January 2000 to December 2010, we identified 37 patients of disseminated histoplasmosis and attempted to characterize the differences between immunocompromised and immunocompetent patients. Demographic characteristics, clinical presentation, risk factors, laboratory findings, diagnostic yield, treatment received and prognosis were noted and compared between the two groups. Results. Eleven of 37 patients with disseminated histoplasmosis were immunocompromised and 26 were immunocompetent. Comparison of their clinical features showed a higher frequency of skin lesions in the immunocompromised compared to the immunocompetent group (54.5% v. 11.5%). Pancytopenia and anaemia were more common among the immunocompromised (81.8%) compared to the immunocompetent (46.2%) group. In the immunocompromised patients, the diagnosis was made most often by bone marrow aspirate and culture (72.7%) compared to the immunocompromised group where the diagnosis was most often obtained by adrenal gland biopsy and fungal cultures (57.7%). The cure rate was significantly higher in the immunocompetent group (73% v. 45%). Conclusion. The clinical presentation and outcome of patients with disseminated histoplasmosis differs among immunocompromised and immunocompetent patients.


Assuntos
Glândulas Suprarrenais/patologia , Adulto , Anemia/imunologia , Anemia/microbiologia , Antifúngicos/uso terapêutico , Biópsia , Medula Óssea/patologia , Feminino , Histoplasmose/complicações , Histoplasmose/diagnóstico , Histoplasmose/tratamento farmacológico , Humanos , Imunocompetência , Hospedeiro Imunocomprometido , Masculino , Pessoa de Meia-Idade , Pancitopenia/imunologia , Pancitopenia/microbiologia , Dermatopatias/imunologia , Dermatopatias/microbiologia , Resultado do Tratamento
2.
Artigo em Inglês | IMSEAR | ID: sea-139178

RESUMO

Background. Leptospirosis is primarily a disease of wild and domestic mammals. Man is infected either directly through contact with an infected animal or indirectly by water or soil contaminated with the urine of an infected animal. We studied the incidence of leptospirosis in patients presenting with an acute febrile illness of more than 7 days to a tertiary care hospital in northern India. Methods. This study was done over a period of 1 year and included 647 patients who presented with an acute febrile illness for more than 7 days. These patients were screened for leptospirosis using the Dri-Dot test and ELISA. Results. Using the Dri-Dot screening test, 244 of 647 patients (37.7%) were positive for leptospirosis. Of these 244 patients, 200 (82%) were positive by ELISA. Conclusion. Leptospirosis is common in northern India and should be considered as a possible differential diagnosis in patients with an acute febrile illness of more than 7 days’ duration.


Assuntos
Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Feminino , Hospitais/estatística & dados numéricos , Humanos , Incidência , Índia/epidemiologia , Leptospirose/epidemiologia , Masculino , Pessoa de Meia-Idade , Estudos Soroepidemiológicos , Adulto Jovem , Zoonoses/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA